Chicago Equity Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$959K Buy
108,070
+96,900
+868% +$1.4M 0.1% 294
2019
Q4
$202K Buy
+11,170
New +$186K 0.01% 827
2018
Q4
Sell
-43,932
Closed -$1.73M 816
2018
Q3
$1.73M Sell
43,932
-281,703
-87% -$12.3M 0.05% 412
2018
Q2
$14.4M Sell
325,635
-25,820
-7% -$1.28M 0.44% 40
2018
Q1
$17.1M Sell
351,455
-63,264
-15% -$3.16M 0.55% 27
2017
Q4
$20.8M Sell
414,719
-12,180
-3% -$638K 0.63% 22
2017
Q3
$21.6M Buy
426,899
+156,745
+58% +$7.39M 0.68% 18
2017
Q2
$10.2M Sell
270,154
-55,056
-17% -$2.17M 0.28% 95
2017
Q1
$12.5M Buy
325,210
+12,130
+4% +$365K 0.36% 79
2016
Q4
$6.92M Buy
313,080
+193,690
+162% +$3.98M 0.18% 133
2016
Q3
$1.91M Buy
+119,390
New +$1.36M 0.05% 308

Other funds holding CC

Chicago Equity Partners's CC Position: Q1 2020 in Review

Chicago Equity Partners increased its Chemours (CC) stake by 868% in Q1 2020, buying an estimated $1.4M and bringing the position to 108,070 shares worth $959K. The position accounts for 0.1% of the portfolio, ranked #294.

Chicago Equity Partners first reported a position in CC in Q3 2016 and has held it in 11 quarters since. The position peaked at $21.6M in Q3 2017. 416 funds tracked by Wall St. Rank hold CC as of Q1 2020.

  • Chicago Equity Partners held 108,070 shares of Chemours worth $959K as of Q1 2020.
  • Chicago Equity Partners bought 96,900 Chemours shares in Q1 2020, an estimated $1.4M.
  • Chemours made up 0.1% of Chicago Equity Partners's portfolio in Q1 2020, its #294 holding.
  • Chicago Equity Partners first reported a position in Chemours in Q3 2016 and has held it in 11 quarters since.
  • Chicago Equity Partners's Chemours position peaked at $21.6M in Q3 2017.
  • 416 funds tracked by Wall St. Rank held Chemours as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.